PHiD-CV dominates PCV-13 in Sweden

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.647, 2012-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PHiD-CV takes top spot

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Pneumococcal Polysaccharide Protein D-Conjugate Vaccine (Synflorix™; PHiD-CV)

By Croxtall Jamie D. Keating Gillian M.

Pediatric Drugs, Vol. 11, Iss. 5, 2009-10 ,pp. : 349-357

Adis International

Access to resources Recommend Favorite

Adult vaccination with PCV13 worth a shot in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 652, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Universal PCV13 proves its worth in Taiwan

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

PCV13 spells cost savings in several settings

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite